Boundless Bio (BOLD) Current Assets (2023 - 2026)
Boundless Bio (BOLD) posted quarterly Current Assets of $94.6 million for Q1 2026, down 32.59% year-over-year from $140.4 million in Q1 2025, and down 13.68% quarter-over-quarter from $109.6 million in Q4 2025.
Boundless Bio (BOLD) Current Assets (2023 - 2026) Analysis & Trends
Boundless Bio (BOLD) has reported Current Assets for 4 consecutive years, with $94.6 million the latest figure, recorded in Q1 2026.
- In Q1 2026, Current Assets fell 32.59% year-over-year to $94.6 million; the TTM figure through Mar 2026 stood at $94.6 million (down 32.59% YoY), while the FY2025 annual figure was $109.6 million, down 29.0% from the prior year.
- Current Assets eased to $94.6 million in Q1 2026 per BOLD's latest filing, from $109.6 million in the prior quarter.
- Across five years, Current Assets topped out at $183.1 million in Q2 2024 and bottomed at $94.6 million in Q1 2026.
- Historically, Current Assets has averaged $133.9 million across 4 years, with a median of $126.9 million in 2023.
- Annual changes were most pronounced in 2025 — Current Assets climbed 25.15% — and 2026, when it tumbled 32.59%.
- Boundless Bio's Current Assets stood at $124.2 million in 2023, then climbed by 24.3% to $154.4 million in 2024, then decreased by 29.0% to $109.6 million in 2025, then retreated by 13.68% to $94.6 million in 2026.
- Business Quant data shows BOLD's Current Assets at $94.6 million in Q1 2026, $109.6 million in Q4 2025, and $120.2 million in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.25 Bn | 131.40 Bn | 2.84 Bn | 12.54 Bn |
| 2 | Regeneron Pharmaceuticals | 86.04 Bn | 78.05 Bn | 3.93 Bn | 18.45 Bn |
| 3 | Argenx Se | 65.43 Bn | 60.25 Bn | 1.37 Bn | 8.07 Bn |
| 4 | Moderna | 58.26 Bn | 53.13 Bn | 52.00 Mn | 5.82 Bn |
| 5 | BeOne Medicines | 42.10 Bn | 37.00 Bn | 1.53 Bn | 7.22 Bn |
| 6 | Alnylam Pharmaceuticals | 31.61 Bn | 28.31 Bn | 992.69 Mn | 4.62 Bn |
| 7 | BioNTech SE | 28.03 Bn | 9.63 Bn | 668.28 Mn | 18.80 Bn |
| 8 | Insmed | 27.49 Bn | 26.33 Bn | 358.27 Mn | 1.63 Bn |
| 9 | Royalty Pharma | 27.33 Bn | 26.49 Bn | - | 1.76 Bn |
| 10 | Boundless Bio | 66.79 Mn | 66.79 Mn | - | 73.65 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 73.65 Mn |
| Mar 31, 2026 | 94.62 Mn |
| Dec 31, 2025 | 109.61 Mn |
| Sep 30, 2025 | 120.16 Mn |
| Jun 30, 2025 | 129.69 Mn |
| Mar 31, 2025 | 140.36 Mn |
| Dec 31, 2024 | 154.39 Mn |
| Sep 30, 2024 | 170.45 Mn |
| Jun 30, 2024 | 183.13 Mn |
| Mar 31, 2024 | 112.16 Mn |
| Dec 31, 2023 | 124.20 Mn |